Menu Close

This novel observation, together with published evidence of chemotaxis activity by IL-17 on airway smooth muscle cells[23], suggests the possibility that other structural or innate/adaptive immune cells could display chemotactic response to Th-17-derived cytokines; if this hypothesis is true, the impact of Th-17 cytokines in asthma pathophysiology and in other chronic inflammatory diseases could have been underestimated

This novel observation, together with published evidence of chemotaxis activity by IL-17 on airway smooth muscle cells[23], suggests the possibility that other structural or innate/adaptive…

Signals of symptom benefit or symptom burden can be included early in the development of a drug to guide the development of dosing recommendations and needed supportive care and to inform potential providers and patient consumers along with those who must approve the agent and those who will determine whether or not to pay for it

Signals of symptom benefit or symptom burden can be included early in the development of a drug to guide the development of dosing recommendations and…